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Does L-carnitine increase serum TNF -α and IGF-1
during liver regeneration in the rat?
Aim: We sought to evaluate the effect of L-carnitine administration on the levels of IGF-1, TNF-α,
and lipid peroxidation during hepatic regeneration for up to 72 h in an experimental partial hepatic
resection rat model.
Materials and methods: Sixty rats were divided into 3 groups: control and low-dose (100 mg/kg) and
high-dose (200 mg/kg) L-carnitine. Each group was divided into 2 sub groups (24 and 72 h after
partial hepatectomy). Partial (70%) hepatectomy was performed after 7 days of intra-peritoneal
administration of L-carnitine. After partial hepatectomy, L-carnitine was also administered to rats
until sacrifice. Serum IGF-1, TNF-α, and tissue malondialdehyde levels were determined in all groups
before and at 24 and 72 h after surgery.
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Results: Serum TNF-α increased significantly in the control group during the regeneration period.
The low dose of L-carnitine (100 mg/kg) decreased the elevation of TNF-α whereas the high dose
(200 mg/kg) increased it. In the control group, the IGF-1 level decreased in the first 24 h after surgery
and then increased. The IGF-1 level behaved similarly in the L-carnitine groups. The
malondialdehyde level in the control group increased during the first 24 h and then decreased.
Similarly in the L carnitine groups, the malondialdehyde level increased during the first 24 h and
then decreased significantly in a dose-dependent manner.
Conclusion: Three types of biochemical pathways are essential in liver regeneration: cytokine, growth
factor, and metabolic pathways. We conclude that, in addition to its effects on energy metabolism,
high-dose L-carnitine may promote liver regeneration by increasing IGF-1, TNF-α, and decreasing
malondialdehyde.
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L-karnitin, karaciğer rejenerasyonu sırasında serum TNF-α ve
IGF-1 düzeylerini artırıyor mu?
Amaç: Rat deneysel parsiyel hepatektomi modelinde L-karnitin uygulamasının 72. saate kadar IGF1, TNF α ve lipid peroksidasyonuna etkisini araştırmayı amaçladık.
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Yöntem ve gereç: Atmış rat kontrol, düşük (100 mg/kg) ve yüksek doz (200 mg/kg) L-karnitin olmak
üzere 3 gruba ayrıldı. Her bir grup, parsiyel hepatektomiden sonra 24 ve 72. saat olmak üzere 2 alt
gruba ayrıldı. Yedi gün intra-peritoneal L-karnitin uygulamasından sonra parsiyel (% 70)
hepatektomi yapıldı. L-karnitin, parsiyel hepatektomiden sonra da ratlara verilmeye devam edildi.
Tüm gruplarda cerrahi operasyondan önce, 24 ve 72 saat sonra serum IGF-1, TNF-α ve doku
malondialdehid düzeyleri ölçüldü.
Bulgular: Kontrol grubunda, serum TNF-α düzeyleri, rejenerasyon boyunca anlamlı derecede arttı.
Düşük doz (100 mg/kg) L-karnitin, TNF-α düzeylerini azaltırken yüksek doz (200 mg/kg) artırdı.
IGF-1 düzeyi, kontrol grubunda cerrahi operasyondan sonra ilk 24 saate azalırken daha sonra
artmaya başladı. L-karnitin gruplarında IGF-1 düzeylerinde benzer değişimler gözlendi.
Malondialdehid düzeyleri kontrol grubunda ilk 24 saatte artarken daha sonra azalmaya başladı.
Benzer şekilde L-karnitin gruplarında malondialdehid düzeyleri ilk 24 saatte artarken daha sonra
doza bağımlı olarak azaldı.
Sonuç: Karaciğer rejenerasyonunda sitokinler, büyüme faktörleri ve metabolik yollar olmak üzere üç
temel unsur bulunmaktadır. Enerji metabolizmasındaki etkilerine ilaveten, yüksek doz L-karnitinin,
IGF-1, TNF-α düzeyini artırarak ve malondialdehid düzeyini de azaltarak karaciğer rejenerasyonunu
hızlandırabileceğini düşünmekteyiz.

coskun2002@gmail.com
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Introduction
Liver regeneration is a process in which liver mass
is restored by a compensatory hyperplastic response
following liver tissue loss or injury. With advances in
anatomical knowledge and surgical techniques, liver
resections are performed with reasonable mortality
and morbidity. In clinical practice, main types of liver
resection are primary malignant tumors and
metastases; benign tumors, such as hemangiomas,
adenomas, and hydatid cysts; trauma; and donor
hepatectomy-related liver transplantations. Recent
advances have resulted in extended resections in
advanced liver lesions. For this reason, regenerative
responses and factors related to liver regeneration are
major concerns in liver surgery.
Various nutritional and pharmacological agents
have been used to promote liver regeneration in
animal models (1,2). In the early phase of liver
regeneration, the energy substrate changes from
glucose to fatty acids (3). L-carnitine is an important
carrier of long-chain free fatty acids from the cytosol
to the mitochondria for β-oxidation and has been
suggested to play a key role in liver regeneration (4,5).
L-carnitine is present in the diet and is synthesized de
novo. The last step of L-carnitine biosynthesis is the
hydroxylation of butyrobetaine to L-carnitine, which
in rats occurs primarily in the liver (6). Blaha and coworkers found that the administration of L-carnitine
stimulated liver regeneration in a dose-dependent
manner (4). Liver regeneration involves a large
number of genes and requires 3 types of pathways:
cytokine, growth factor, and metabolic pathways (7).
In the present study, we investigated the effect of Lcarnitine on the levels of tumor necrosis factor (TNF)α, insulin-like growth factor (IGF)-1, and lipid
peroxidation during liver regeneration for up to 72 h
using a rat model.
Materials and methods
The study was approved by the Animal Care and
Ethics Committee of Düzce School of Medicine.
Experimental procedures were performed in the
animal research laboratory at the same institute. Male
Wistar albino rats (n = 60) weighing 230-290 g (mean,
240 g) were randomly assigned to 6 groups (10 per
group), and partial (70%) hepatectomy (PH) was
876
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performed after 7 day intra-peritoneal administration
®
of L-carnitine (CARNITINE , Sigma Tau, Industrie
Farmaceutiche Riunite S.p.A., Pomezia, Italy) as
described in Table 1. After partial hepatectomy, Lcarnitine was also administered until sacrifice. All rats
were fed a commercial pellet diet and were allowed
water ad libitum.
Anesthesia and surgery
Surgical Technique: All animals were fed in
standard fashion, and no bowel preparation was
applied. After 12 h of fasting, all animals were
anesthetized by intramuscular ketamine 50 mg/kg
(Ketalar,
Parke-Davis,
Eczacıbaşı)
and
chlorpromazine 0.1 mg/kg (Largactil, 25-mg
ampoule; Rhone-Poulenc, Eczacıbaşı). The skin was
cleansed with povidone-iodine after shaving. The liver
was exposed through a midline laparotomy; the left
lateral and median lobes were exposed, and a 70%
hepatectomy was carried out as described by Higgins
and Anderson (8). The incision was closed with 4/0
silk, in a continuous fashion. Rats were re-operated
according to the time plan for each group (Table 1).
Residual liver tissue was resected, and a 2-mL blood
sample was obtained from the inferior vena cava.
Tissue samples were used for the determination of wet
tissue malondialdehyde (MDA), a product of liver
peroxidation.
Biochemical measurements
Serum TNF-α levels were measured by a solidphase sandwich enzyme linked immunosorbent assay
(ELISA; Biosource, Nivelles, Belgium). The minimum
detection limit and within assay CV were 4 pg/mL
and 2.7%, respectively. Serum IGF-1 levels were
measured by enzyme immunoassay (EIA; DSL,
Webster, Texas, USA). The minimum detection limit
and within assay CV were 30 ng/mL and 5.3%,
respectively. Tissue MDA levels were measured using
the method described by Mihara et al. (9).
Statistical analysis
Data are expressed as means ± SDs. Differences
between groups were analyzed using analysis of
variance. For significant F values, differences between
means were analyzed with a post-hoc Tukey test.
Values of P < 0.05 were deemed statistically
significant.
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Table 1. Study design and characteristics of control and treatment groups.
Groups (n = 10)

Medication

Surgical procedure

Second procedure

Group 1

Standard feeding (SF)

70% hepatectomy

Residual liver resection and sacrifice after 24 h

Group 2

SF

70% hepatectomy

Residual liver resection and sacrifice after 72 h

Group 3

SF + L-carnitine (100 mg/kg)

70% hepatectomy

Residual liver resection and sacrifice after 24 h

Group 4

SF + L-carnitine (100 mg/kg)

70% hepatectomy

Residual liver resection and sacrifice after 72 h

Group 5

SF + L-carnitine (200 mg/kg)

70% hepatectomy

Residual liver resection and sacrifice after 24 h

Group 6

SF + L-carnitine (200 mg/kg)

70% hepatectomy

Residual liver resection and sacrifice after 72 h

Results
TNF-α
The TNF-α levels in the groups are presented in
Table 2. In the control group, the serum TNF-α level
increased significantly during regeneration
(161.3 ± 24.5 pg/mL at 72 h, P < 0.001). In
comparison, the elevation of TNF-α decreased in the
low-dose L-carnitine group (56.9 ± 26.9 pg/mL at
72 h, P < 0.001) and increased in the high-dose Lcarnitine group (193.0 ± 38.6 pg/mL at 72 h, P <
0.001).
IGF-1
The serum IGF-1 levels in the groups are
summarized in Table 3. In the control group, the IGF1 level at 24 h was decreased compared with that at 0
h (762 ± 381 ng/mL vs. 2011 ± 295 ng/mL,
respectively); the IGF-1 level was increased
significantly by 72 h (1513 ± 436 ng/mL) but was still
below that at 0 h. At 0 h, the IGF-1 level in the highdose L-carnitine group was below the levels in the
control and low-dose L-carnitine groups. In
comparison with the changes in IGF-l levels in the

control and low-dose L-carnitine groups, the IGF-1
level in the high-dose L-carnitine group decreased at
a lower rate during the first 24 h and then increased at
a higher rate by 72 h (P < 0.01).
MDA
The liver MDA levels in the groups are shown in
Table 4. In the control group, the MDA level increased
significantly during the first 24 h (P < 0.001) and then
slightly decreased, although this decrease was not
statistically significant (P > 0.05). In the low-dose Lcarnitine group, the MDA level increased during the
first 24 h and then decreased significantly (P < 0.01).
In the high-dose L-carnitine group, the elevation of
the MDA level during the first 24 h was not
statistically significant; however, after 24 h, the MDA
level decreased significantly (P < 0.01) in comparison
with the levels at 0 and 24 h.
Discussion
In mammals, including humans, liver regeneration
is one of the most rapid forms of tissue growth. In the

Table 2. Serum TNF-α levels in control and treatment groups administered L-carnitine.

Groups

TNF-α at 0 h
b,c

TNF-α at 24 h

TNF-α at 72 h

61.9 ± 23.0 pg/mLa,c

161.3 ± 24.5 pg/mLa,b

Control

25.9 ± 6.1 pg/mL

L-Carnitine (100 mg/kg)

28.8 ± 11.8 pg/mLc

36.9 ± 12.7 pg/mL

56.9 ± 26.9 pg/mLa

L-Carnitine (200 mg/kg)

13.5 ± 5.0 pg/mLc

37.0 ± 12.6 pg/mLc

193.0 ± 38.6 pg/mLa,b

Values are given as means ± SD. a: significantly different vs. 0 h; b: significantly different vs. 24 h; c: significantly different vs. 72 h.
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Table 3. Serum IGF-1 levels in control and treatment groups administered L-carnitine.
Groups
Control
L-Carnitine (100 mg/kg)
L-Carnitine (200 mg/kg)

IGF-1 at 0 h

IGF-1 at 24 h

IGF-1 at 72 h

2011 ± 295 ng/mLb,c
1935 ± 205ng/mLb,c
1370 ± 288ng/mLb

762 ± 381ng/mLa,c
892 ± 187ng/mLa,c
838 ± 152ng/mLa,c

1513 ± 436ng/mLa,b
1411 ± 425ng/mLa,b
1407 ± 280ng/mLb

Values are given as means ± SD. a: significantly different vs. 0 h; b: significantly different vs. 24 h; c: significantly different vs. 72 h.
Table 4. Liver MDA levels (nmol/mg wet tissue) in control and treatment groups administered L-carnitine.
Groups

MDA at 0 h

Control

29.3 ± 9.8

L-Carnitine (100 mg/kg)

37.7 ± 12.8b

L-Carnitine (200 mg/kg)

c

b,c

52.6 ± 22.0

MDA at 24 h

MDA at 72 h

55.1 ± 16.4a

47.8 ± 11.1a

77.0 ± 18.4a,c

54.0 ± 15.6b

71.3 ± 18.9

c

29.9 ± 10.1a,b

Values are given as means ± SD. a: significantly different vs. 0 h; b: significantly different vs. 24 h; c: significantly different vs. 72 h.

present study, we investigated whether L-carnitine, in
addition to its role in lipid metabolism, promotes liver
regeneration by modulating key molecules, such as
TNF-α and IGF-1, which are critical in the initiation
and process of liver regeneration in a rat model.
L-carnitine is an amino acid synthesized from
lysine and methionine by an iron- and ascorbatedependent pathway in the liver, kidney, and brain. Its
main function is the transport of long-chain fatty
acids from the cytosol into the mitochondria for βoxidation and ATP production. In addition, Lcarnitine stabilizes membrane fluidity, which is
important in maintaining cellular homeostasis
through the regulation of several membrane-linked
systems (10,11). In adult humans, one-third of the
daily L-carnitine requirement is met by endogenous
synthesis, and two-third is from the diet (12). Lcarnitine deficiency has been observed in cirrhosis,
renal failure, long-term total parenteral or enteral
nutritional therapy, and premature infants (12). It has
been reported that after PH, the L-carnitine
concentration in the remnant liver and serum were
sufficient for liver regeneration (5). Lai et al. have
suggested that kidney and skeletal muscle release their
stored L-carnitine into the serum after PH, and
consequently the flow of L-carnitine to the liver
increases (5).
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In the priming phase, which occurs during the first
few hours after PH, a wide variety of genes, many of
which are related to cytokine networks, are
differentially expressed, and liver mRNA and serum
levels of TNF-α and interleukin-6 are increased (1315). The cytokine cascade is initiated by the binding of
TNF-α to its receptor, TNFR1, resulting in the
activation of nuclear factor-kappa B (NF-κB) in nonparenchymal cells, the production of interleukin-6,
and the activation of signal transducer and activator
of transcription 3 (STAT-3) in hepatocytes (7). After
PH, the cytokine network is activated within 30 min
(7). In our study, serum TNF-α increased significantly
in the control group; however, low-dose L-carnitine
(100 mg/kg) decreased the elevation in TNF-α, and
high-dose L-carnitine increased it compared with the
control and low-dose groups. We thought that highdose L-carnitine administration might promote liver
regeneration by increasing the TNF-α level during the
regeneration period after PH. After PH, the activity
of several matrix metalloproteinases (MMPs)
increases, and cytokines, such as TNF-α, activate
MMPs, which may be a link between cytokines and
growth factors (7,16). During liver regeneration, the
activation of cytokines and growth factor receptors
may initiate several intracellular pathways, which are
important for cell survival and proliferation (7). For
example, Argast and co-workers found that, in
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cultured hepatocytes, TNF-α activated TGFα
converting enzyme, resulting in the release of TGFα,
the activation of epidermal growth factor receptor,
and cell proliferation (17).
Cytokines, growth factors, and metabolic pathways
interact during liver regeneration (7). In the priming
phase, cytokine network activation causes quiescent
hepatocytes to enter the cell cycle (G0 to G1), and
then growth factors, such as hepatocyte growth factor
(HGF) and the epidermal growth factor receptor
ligand family, drive cell cycle progression (18,19).
Borowiak and co-workers demonstrated that HGF/cmet signaling was essential for cell cycle entry after
PH (20). Furthermore, Huh et al. concluded that
HGF/c-met signaling was important in the healing of
hepatocytes after CCl4 administration (21). The
activation of cytokine receptors, particularly TNF-α,
is important for the initiation of liver regeneration,
whereas growth factors usually act later on
hepatocytes (22,23). IGF-1 is synthesized primarily in
the liver; however, it has no significant effect on
hepatocytes because hepatocytes do not express IGF1 receptors (24). In contrast, IGF-1 has paracrine
effects within the liver, because non-parenchymal
cells, such as Kuppfer cells, do express IGF-1 receptors
and thus IGF-1 can stimulate these cells (25). Patricia
and co-workers studied growth hormone receptor
(GHR) and IGF-1 gene expression before and after
PH (26). They found a significant decrease in GHR
and IGF-1 mRNA levels during the first 24 h after PH
compared with the basal levels before surgery (26).
They also found that GHR levels returned to basal
levels within 4 days after surgery, whereas IGF-1 levels
returned to basal values within 7 days after surgery
(26). In our study, we found that L-carnitine
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administered before surgery decreased IGF-1 levels
compared with control levels. In all of the groups,
serum IGF-1 levels decreased within the first 24 h
after PH and then increased significantly by 72 h. LCarnitine administration slowed the decrease in IGF1, and IGF-1 increased at a higher rate and in a
dose-dependent manner after 24 h. High-dose Lcarnitine administration also returned IGF-1 to 0 h
levels within 3 days after surgery.
In our study, the administration of L-carnitine
before surgery increased MDA levels, which
decreased after surgery. The anti-oxidative effects of
L-carnitine have been examined in various studies
(27,28). Derin et al. have shown that L-carnitine
pretreatment increases catalase activity after ischemia
reperfusion in rats (27). Reznick et al. suggested that
L-carnitine scavenges hydroxyl radicals and inhibits
hydroxyl radical formation by the Fenton reaction
(28).
In summary, our data show that the
administration of L-carnitine before PH decreased the
TNF-α and IGF-1 levels and increased the MDA level
in a dose-dependent manner. In contrast, the
administration of L-carnitine after PH had positive
effects on the TNF-α and IGF-1 levels and also had
anti-oxidative effects. Based on these and previously
reported findings, we conclude that L-carnitine
should be administered after rather than before PH to
promote liver regeneration in rats.
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